Contineum Therapeutics, Inc. (CTNM)
17.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
17.04
0.00 (0.00%)
After-Hours: 16:37
Contineum Therapeutics 1 Year Total Returns (Daily) : 64.10% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 64.10% |
| August 24, 2026 | 67.30% |
| August 21, 2026 | 71.22% |
| August 20, 2026 | 80.61% |
| August 19, 2026 | 72.26% |
| August 18, 2026 | 79.01% |
| August 17, 2026 | 96.88% |
| August 14, 2026 | 95.45% |
| August 13, 2026 | 120.1% |
| August 12, 2026 | 121.9% |
| August 11, 2026 | 130.5% |
| August 10, 2026 | 124.0% |
| August 07, 2026 | 123.5% |
| August 06, 2026 | 142.5% |
| August 05, 2026 | 154.5% |
| August 04, 2026 | 174.1% |
| August 03, 2026 | 167.3% |
| July 31, 2026 | 162.5% |
| July 30, 2026 | 162.1% |
| July 29, 2026 | 176.5% |
| July 28, 2026 | 157.0% |
| July 27, 2026 | 140.2% |
| July 24, 2026 | 146.7% |
| July 23, 2026 | 161.3% |
| July 22, 2026 | 184.4% |
| Date | Value |
|---|---|
| July 21, 2026 | 146.0% |
| July 20, 2026 | 211.0% |
| July 17, 2026 | 270.6% |
| July 16, 2026 | 265.8% |
| July 15, 2026 | 288.1% |
| July 14, 2026 | 290.6% |
| July 13, 2026 | 273.0% |
| July 10, 2026 | 276.9% |
| July 09, 2026 | 285.3% |
| July 08, 2026 | 299.2% |
| July 07, 2026 | 282.2% |
| July 06, 2026 | 300.3% |
| July 02, 2026 | 277.5% |
| July 01, 2026 | 295.8% |
| June 30, 2026 | 312.8% |
| June 29, 2026 | 265.0% |
| June 26, 2026 | 253.9% |
| June 25, 2026 | 191.1% |
| June 24, 2026 | 183.0% |
| June 23, 2026 | 189.1% |
| June 22, 2026 | 144.1% |
| June 18, 2026 | 227.1% |
| June 17, 2026 | 209.4% |
| June 16, 2026 | 189.0% |
| June 15, 2026 | 187.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cocrystal Pharma, Inc. | -26.62% |
| CNBX Pharmaceuticals, Inc. | -62.50% |
| GB Sciences, Inc. | 50.00% |
| Arvinas, Inc. | 28.34% |
| Fulcrum Therapeutics, Inc. | -39.78% |